Effect of Irbesartan on Proteinuria in the Patients with Diabetic Nephropathy
HE Ming-h
Abstract
HE Ming-h
Abstract
Object:To observe the effect of angiotension Ⅱ receptor antagonists(ATRA) irbesartan on proteinuria in the patients with diabetic nephropathy.Methods 49 patients with diabetic nephropathy were conducted into two groups,26 patients treated with irbesartan 150mg per day and 23 patients with enalapril 10mg per day for 3 months.To observe the vary with proteinuria and microalbuminuria on pre-treated and post-treated.Results Itreating and control groups,proteinuria and microalbuminuria were evidently reduced,in treating group,proteinuria decreased from(0.85±0.34)g/24h to(0.44±0.19)g/24h (P0.001),microalbuminuria decreased from(351.42±159.34)mg/24h to (160±87.59)mg/24h(P0.001)In enalapril group,proteinuria decreased from (0.96±.42)g/24h to(0.44±0.17)g/24h(P0.001),microalbuminuria decreased from(345.42±170.96)mg/24h to(177.26±97.03)mg/24h(P0.001).Conclusion ATRA irbesartan can reduce proteinuria of diabetic nephropathy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Object:To observe the effect of angiotension Ⅱ receptor antagonists(ATRA) irbesartan on proteinuria in the patients with diabetic nephropathy.Methods 49 patients with diabetic nephropathy were conducted into two groups,26 patients treated with irbesartan 150mg per day and 23 patients with enalapril 10mg per day for 3 months.To observe the vary with proteinuria and microalbuminuria on pre-treated and post-treated.Results Itreating and control groups,proteinuria and microalbuminuria were evidently reduced,in treating group,proteinuria decreased from(0.85±0.34)g/24h to(0.44±0.19)g/24h (P0.001),microalbuminuria decreased from(351.42±159.34)mg/24h to (160±87.59)mg/24h(P0.001)In enalapril group,proteinuria decreased from (0.96±.42)g/24h to(0.44±0.17)g/24h(P0.001),microalbuminuria decreased from(345.42±170.96)mg/24h to(177.26±97.03)mg/24h(P0.001).Conclusion ATRA irbesartan can reduce proteinuria of diabetic nephropathy.
Key concepts: Irbesartan, Proteinuria, Medicine, Microalbuminuria, Enalapril, Urology, Diabetic nephropathy, Internal medicine